Spin-Off

A new partnership between power module expert SOLUM and charger innovator i-charging aims to supercharge e-mobility with next-gen tech and a human-centric vision.

As LunR Royalties begins trading, its parent NGEx Minerals pivots to unlock the potential of its world-class copper-gold assets in South America.

A simple, low-cost heart pill may hold the key to treating Alzheimer's and kidney disease. CardioPharma is now funding research to unlock its potential.

Following a major legal victory in Peru, American Lithium will spin out its massive Macusani uranium project to capitalize on a surging nuclear energy market.

GrantWatch founder Libby Hikind is trading grant databases for picture books. Discover the strategy behind her pivot to value-driven children's literature.

Nasdaq-listed Society Pass is ditching its e-commerce roots for the AI gold rush. Is this a savvy M&A masterstroke or a risky gamble in a capital-heavy arena?

Serve Robotics and Uber Eats launch sidewalk robots in Alexandria, Va., testing the scalability, economics, and public acceptance of last-mile automation.

BridgeBio Oncology's new drug candidate BBO-10203 could redefine cancer therapy by avoiding a key toxicity, unlocking a vast market.

Daré Bioscience is targeting a 20M-woman market with a novel arousal cream. This is the story of its clever regulatory strategy and high-stakes bet.

Ledger Investing launches Korra, a battle-tested SaaS platform using AI to bring transparency and efficiency to the complex casualty ILS market.

Prospect Enhanced Yield Fund's debut 9% distribution tempts income seekers, but a look into the structured credit market reveals a complex risk-reward.

A medical breakthrough dismantles a core barrier in cancer treatment, making stem cell transplants a reality for nearly everyone, regardless of ancestry.

As new laws bring clarity to digital currencies, WSPN is offering enterprises the tools to mint their own, accelerating a shift in global finance.